Mishra Pooja, Faruqui Tabrez, Khanam Sheeba, Khubaib Mohd, Ahmad Irfan, Saeed Mohd, Khan Salman
Department of Biosciences, Integral University, Lucknow, Uttar Pradesh, India.
Department of Clinical Laboratory Sciences, College of Applied Medical Science, King Khalid University, Abha, Saudi Arabia.
Front Mol Biosci. 2024 Sep 25;11:1469107. doi: 10.3389/fmolb.2024.1469107. eCollection 2024.
The sustained synthesis of gold nanoparticles (GNPs) has gained significant attention in biomedical applications. In this study, we explored the antibacterial and anticancer potential of bakuchiol-mediated gold nanoparticles (Bak-GNPs). Bakuchiol, a natural compound found in seeds, serves as both a reducing and stabilizing agent for green synthesis of GNPs. Our objectives include network analysis, molecular docking, synthesis of GNPs, characterization, and antipathogenic and anticancer efficacy of Bak-GNPs against lung and liver cancers.
Protein-protein interaction networks were analyzed to identify effective protein targets for bakuchiol in lung and liver cancers. A molecular docking study was performed to validate the efficacy of the target protein against lung and liver cancer. Furthermore, Bak-GNPs were synthesized using bakuchiol and characterized by various techniques such as UV-visible spectroscopy, dynamic light scattering (DLS), zeta potential transmission electron microscopy (TEM), and Fourier-transform infrared (FTIR) spectroscopy, and their potential against pathogens and lung and liver cancers.
GNAI3 emerged as the most promising target, with a binding energy of -7.5 kcal/mol compared to PTGER3's -6.9 kcal/mol, different characterization techniques revealed the successful synthesis of Bak-GNPs. Bak-GNPs exhibited potent antibacterial activity against both Gram-positive and Gram-negative bacteria, as confirmed by minimum inhibitory concentration (MIC) values. Bak-GNPs demonstrated significant anticancer effects on A549 (lung cancer) and HepG2 (liver cancer) cells, with IC values of 11.19 μg/mL and 6.6 μg/mL, respectively. Induction of apoptosis and inhibition of cell proliferation were observed in both the cell lines. The increased production of reactive oxygen species (ROS) contributes to its anticancer effects.
This study highlights promising biomedical applications of bakuchiol-mediated GNPs. This green synthesis approach using bakuchiol provides a sustainable method for producing nanoparticles with enhanced biological activities. Further exploration of the pharmacological properties and mechanisms of Bak-GNPs is required to optimize their therapeutic efficacy for clinical use.
金纳米颗粒(GNPs)的持续合成在生物医学应用中受到了广泛关注。在本研究中,我们探索了补骨脂酚介导的金纳米颗粒(Bak-GNPs)的抗菌和抗癌潜力。补骨脂酚是一种存在于种子中的天然化合物,在金纳米颗粒的绿色合成中既是还原剂又是稳定剂。我们的目标包括网络分析、分子对接、金纳米颗粒的合成、表征以及Bak-GNPs对肺癌和肝癌的抗病原体及抗癌功效。
分析蛋白质-蛋白质相互作用网络,以确定补骨脂酚在肺癌和肝癌中的有效蛋白靶点。进行分子对接研究,以验证靶蛋白对肺癌和肝癌的疗效。此外,使用补骨脂酚合成Bak-GNPs,并通过紫外可见光谱、动态光散射(DLS)、zeta电位、透射电子显微镜(TEM)和傅里叶变换红外(FTIR)光谱等各种技术对其进行表征,以及它们对病原体和肺癌及肝癌的潜力。
与PTGER3的-6.9 kcal/mol相比,GNAI3成为最有前景的靶点,结合能为-7.5 kcal/mol,不同的表征技术表明成功合成了Bak-GNPs。最小抑菌浓度(MIC)值证实,Bak-GNPs对革兰氏阳性菌和革兰氏阴性菌均表现出强大的抗菌活性。Bak-GNPs对A549(肺癌)和HepG2(肝癌)细胞显示出显著的抗癌作用,IC值分别为11.19 μg/mL和6.6 μg/mL。在两种细胞系中均观察到细胞凋亡的诱导和细胞增殖的抑制。活性氧(ROS)产量增加有助于其抗癌作用。
本研究突出了补骨脂酚介导的金纳米颗粒在生物医学应用方面的前景。这种使用补骨脂酚的绿色合成方法为生产具有增强生物活性的纳米颗粒提供了一种可持续的方法。需要进一步探索Bak-GNPs的药理特性和作用机制,以优化其临床治疗效果。